GH1 and renal cell carcinoma: Simvastatin was shown to suppress phosphorylation of JAK2 and STAT3 in two human renal cell carcinoma cell lines in a nude mouse model [46] and growth hormone-stimulated JAK2 and STAT5 activation in osteosarcoma cells [47].